Review



hapln 771  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems hapln 771
    Hapln 771, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 37 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hapln1/Human+HAPLN1+Antibody/pm41309656-367-94-97
    Average 94 stars, based on 37 article reviews
    hapln 771 - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Western Blot:

    Article Title: Increased levels of extracellular matrix proteins associated with extracellular vesicles from brains of aged mice
    Article Snippet: Membranes were then incubated with species‐matched IRDye‐conjugated secondary antibodies (Li‐COR Biosciences) and imaged on an Odyssey scanner (Li‐COR Biosciences). .. The following primary antibodies were used for immunoblots: CD81 (sc‐166029, mouse monoclonal, Santa Cruz Biotechnology), Flotillin‐1 (610820, mouse monoclonal, BD Transduction Laboratories), HSP‐70 (sc‐32239, mouse monoclonal, Santa Cruz Biotechnology), Grp94 (sc‐32249, rat monoclonal, Santa Cruz Biotechnology), Cytochrome C (sc‐13156, mouse monoclonal, Santa Cruz Biotechnology), Histone H3 (4499, rabbit monoclonal, Cell Signaling Technology), Hapln1 (AF2608, goat polyclonal, R&D Systems), and Hapln2 (sc‐376797, mouse monoclonal, Santa Cruz Biotechnology and NBP1‐91977, rabbit polyclonal, Novus Biologicals). ..

    other:

    Article Title: Aggrecan protects against plaque accumulation and is essential for proper microglial responses to plaques
    Article Snippet: Hemispheres were either fresh-frozen on dry ice for biochemical analysis, flash-frozen in isopentane for spatial transcriptomics, or drop-fixed in 4% paraformaldehyde for immunohistochemical (IHC) analysis.

    Recombinant:

    Article Title: Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4
    Article Snippet: .. Biotin end-labeled 50 kDa hyaluronan (bHA; HYA-B50-200507), 50 kDa HA (Hya-50-KEF-1), and 150 kDa HA (160K-0504) were obtained from Hyalose LLC or through Echelon Biosciences Inc. Recombinant human proteins TSG-6 (Trp18-Leu277; #2104-TS), HAPLN1 (Asp16-Asn 354; #2608-HP), and HABP (Aggrecan G1-IGD-G2 domain, Val20-Gly675; #1220-PG), with C-terminal 10-His tags, expressed in mouse myeloma cells, were purchased from R&D Systems Inc. Recombinant human VG1 (#G-HA01, expressed in E. Coli , no tag) was obtained from Echelon Biosciences. ..

    Immunohistochemistry:

    Article Title: Determining the role of microglia in the diurnal regulation of perineuronal nets and the impact of perineuronal nets in Alzheimer’s disease
    Article Snippet: .. Immunohistochemistry 35 Primary antibodies/stains used and dilutions are as follows: WFA (1:1000, B-1355, Vector Labs), ACAN (1:200, AB1031, Millipore), OC (1:1000; AB2286; Sigma-Aldrich), IBA1 (1:1000, 019– 19741, Wako; and 1:500, 234 009, Synaptic Systems), LAMP1 (1:200; AB25245, Abcam), CD11c (1:100.; 50–112-2633; eBioscience), CS-56 (1:200; ab11570, Abcam), CS-6 mAb clone 3B3 (1:20, PRPG-BC-M04, Cosmo Bio USA), HAPLN1 (1:50; AF2608, R&D Systems, Minneapolis, MN), TNR (1:200; 217 008, Synaptic Systems, Germany). .. Amylo-Glo staining (TR-300-AG; Biosensis, Thebarton, South Australia, AU) was performed before blocking tissue and according to manufacturer's instructions to visualize fibrillar Aβ plaques.

    Blocking Assay:

    Article Title: Perineuronal Net and Inhibitory Synapse Remodeling on Striatal Fast-spiking Interneurons by Chronic Alcohol Exposure
    Article Snippet: Gels were electroblotted onto nitrocellulose membrane (0.45 μ pore size) using XCell II Blot Module (ThermoFisher). .. Membranes were blocked in Intercept blocking buffer (1:2 in TBS; Li- Cor) for 2h at room temperature before incubation overnight 4 °C in primary antibody: HAPLN1 (Goat; 1:1,000; R&D Systems # AF2608) or Aggrecan (Rabbit; 1:1,000; Millipore # AB1031). .. Membranes were washed three times for 10 min in TBS-T (0.1% Tween 20) before incubation in secondary antibodies: Donkey anti-rabbit (IRDye 926; 1:10,000; Li-Cor or Donkey anti-goat (IRDye 800; 1:10,000; Li-Cor).

    Incubation:

    Article Title: Perineuronal Net and Inhibitory Synapse Remodeling on Striatal Fast-spiking Interneurons by Chronic Alcohol Exposure
    Article Snippet: Gels were electroblotted onto nitrocellulose membrane (0.45 μ pore size) using XCell II Blot Module (ThermoFisher). .. Membranes were blocked in Intercept blocking buffer (1:2 in TBS; Li- Cor) for 2h at room temperature before incubation overnight 4 °C in primary antibody: HAPLN1 (Goat; 1:1,000; R&D Systems # AF2608) or Aggrecan (Rabbit; 1:1,000; Millipore # AB1031). .. Membranes were washed three times for 10 min in TBS-T (0.1% Tween 20) before incubation in secondary antibodies: Donkey anti-rabbit (IRDye 926; 1:10,000; Li-Cor or Donkey anti-goat (IRDye 800; 1:10,000; Li-Cor).



    Similar Products

    94
    NSJ Bioreagents hapln1
    Hapln1, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hapln1/HAPLN1+Antibody/bio_rxiv__64898__2026__05__21__726929-82-28-30
    Average 94 stars, based on 1 article reviews
    hapln1 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Bio-Techne corporation recombinant human hapln1 protein, cf
    Recombinant Human Hapln1 Protein, Cf, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hapln1/Recombinant+Human+HAPLN1+Protein%2C+CF/bio-techne+corporation___2608-hp
    Average 94 stars, based on 1 article reviews
    recombinant human hapln1 protein, cf - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Absolute Biotech Inc hapln1
    Hapln1, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hapln1/anti+laminin/pm41931615-286-24-27
    Average 86 stars, based on 1 article reviews
    hapln1 - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    R&D Systems hapln 771
    Hapln 771, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hapln1/Human+HAPLN1+Antibody/pm41309656-367-94-97
    Average 94 stars, based on 1 article reviews
    hapln 771 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    R&D Systems hapln
    a Left: photomicrographs of immunohistochemically labeled hyaluronan and proteoglycan link protein 1 <t>(HAPLN1),</t> <t>aggrecan,</t> and tyrosine hydroxylase (TH) from the ventral tegmental area (VTA) of a late-middle-aged mouse. Numbered images in middle panel correspond to numbered fields of view within white squares in the left panels. Right panels depict the fields of view delineated by white squares in middle panel. Right: photomicrographs depicting HAPLN1 and aggrecan deposition on dopamine neuron surfaces, and the peri-dopamine neuron region of interest used to estimate protein abundances at neuronal membranes. Experiments were performed once on a single cohort of mice. b Boxplots depicting field of view coverage of HAPLN1 and aggrecan in the VTA of young-adult (black; n = 8 mice), aging-unimpaired (AU; green; n = 6 mice), and aging-impaired (AI; yellow; n = 4 mice) mice (n-Way ANOVA; post-hoc Tukey-Kramer; <t>HAPLN:</t> p = 0.022; Aggrecan: p = 0.25). c Boxplots depicting HAPLN1-DA neuron, aggrecan-DA neuron, and HAPLN1-aggrecan-DA neuron puncta densities in young-adult ( n = 8 mice), aging-unimpaired (AU; n = 6 mice), and aging-impaired (AI; n = 4 mice) mice (n-Way ANOVA; two-sided; HAPLN1-DA: p = 0.029; Aggrecan-DA: p = 0.62; HAPLN-Aggrecan-DA: p = 0.031). d Schematic of the analysis strategy used to examine hyaluronan and Homer2 on dopamine neurons (Homer-DA neuron). Experiments were performed once on a single cohort of mice. e Boxplots depicting homer-DA neuron puncta densities in young-adult (black) and late-middle-aged (gray) sedentary (squares) and behavior-trained (triangles) mice (n-way ANOVA; two-sided; Behavior: p = 0.65; n = 8 young-sedentary; 12 young-behavior; 8 middle-aged-sedentary; 12 middle-aged-behavior mice). f Relationship between homer-DA neuron puncta densities and performance on foraging task (robust regression; two-sided; Young: p = 0.91; Middle-aged: p = 0.039). g Scatter plots of hyaluronan-DA neuron puncta densities plotted against Homer2-DA neuron puncta densities in sedentary and behavior-trained mice (robust regression; two-sided; Young Sedentary: p = 0.34; Middle-aged Sedentary: p = 0.14; Young Behavior: p = 0.0036; Middle-aged Behavior: p = 0.0068). In all boxplots, boxes represent interquartile ranges (IQR; 25–75 percentiles), middle lines represent medians, and whiskers extend +/− 1.5*IQR. Source data are provided in the file - Fig. 7 and all statistics are provided in Supplementary Data . * represents p < 0.05.
    Hapln, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hapln1/Human+HAPLN1+Antibody/pmc12722224-390-120-122
    Average 94 stars, based on 1 article reviews
    hapln - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    R&D Systems hapln1
    a Left: photomicrographs of immunohistochemically labeled hyaluronan and proteoglycan link protein 1 <t>(HAPLN1),</t> <t>aggrecan,</t> and tyrosine hydroxylase (TH) from the ventral tegmental area (VTA) of a late-middle-aged mouse. Numbered images in middle panel correspond to numbered fields of view within white squares in the left panels. Right panels depict the fields of view delineated by white squares in middle panel. Right: photomicrographs depicting HAPLN1 and aggrecan deposition on dopamine neuron surfaces, and the peri-dopamine neuron region of interest used to estimate protein abundances at neuronal membranes. Experiments were performed once on a single cohort of mice. b Boxplots depicting field of view coverage of HAPLN1 and aggrecan in the VTA of young-adult (black; n = 8 mice), aging-unimpaired (AU; green; n = 6 mice), and aging-impaired (AI; yellow; n = 4 mice) mice (n-Way ANOVA; post-hoc Tukey-Kramer; <t>HAPLN:</t> p = 0.022; Aggrecan: p = 0.25). c Boxplots depicting HAPLN1-DA neuron, aggrecan-DA neuron, and HAPLN1-aggrecan-DA neuron puncta densities in young-adult ( n = 8 mice), aging-unimpaired (AU; n = 6 mice), and aging-impaired (AI; n = 4 mice) mice (n-Way ANOVA; two-sided; HAPLN1-DA: p = 0.029; Aggrecan-DA: p = 0.62; HAPLN-Aggrecan-DA: p = 0.031). d Schematic of the analysis strategy used to examine hyaluronan and Homer2 on dopamine neurons (Homer-DA neuron). Experiments were performed once on a single cohort of mice. e Boxplots depicting homer-DA neuron puncta densities in young-adult (black) and late-middle-aged (gray) sedentary (squares) and behavior-trained (triangles) mice (n-way ANOVA; two-sided; Behavior: p = 0.65; n = 8 young-sedentary; 12 young-behavior; 8 middle-aged-sedentary; 12 middle-aged-behavior mice). f Relationship between homer-DA neuron puncta densities and performance on foraging task (robust regression; two-sided; Young: p = 0.91; Middle-aged: p = 0.039). g Scatter plots of hyaluronan-DA neuron puncta densities plotted against Homer2-DA neuron puncta densities in sedentary and behavior-trained mice (robust regression; two-sided; Young Sedentary: p = 0.34; Middle-aged Sedentary: p = 0.14; Young Behavior: p = 0.0036; Middle-aged Behavior: p = 0.0068). In all boxplots, boxes represent interquartile ranges (IQR; 25–75 percentiles), middle lines represent medians, and whiskers extend +/− 1.5*IQR. Source data are provided in the file - Fig. 7 and all statistics are provided in Supplementary Data . * represents p < 0.05.
    Hapln1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hapln1/Human+HAPLN1+Antibody/pmc12445281-277-52-55
    Average 94 stars, based on 1 article reviews
    hapln1 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    R&D Systems goat anti hapln1
    a Left: photomicrographs of immunohistochemically labeled hyaluronan and proteoglycan link protein 1 <t>(HAPLN1),</t> <t>aggrecan,</t> and tyrosine hydroxylase (TH) from the ventral tegmental area (VTA) of a late-middle-aged mouse. Numbered images in middle panel correspond to numbered fields of view within white squares in the left panels. Right panels depict the fields of view delineated by white squares in middle panel. Right: photomicrographs depicting HAPLN1 and aggrecan deposition on dopamine neuron surfaces, and the peri-dopamine neuron region of interest used to estimate protein abundances at neuronal membranes. Experiments were performed once on a single cohort of mice. b Boxplots depicting field of view coverage of HAPLN1 and aggrecan in the VTA of young-adult (black; n = 8 mice), aging-unimpaired (AU; green; n = 6 mice), and aging-impaired (AI; yellow; n = 4 mice) mice (n-Way ANOVA; post-hoc Tukey-Kramer; <t>HAPLN:</t> p = 0.022; Aggrecan: p = 0.25). c Boxplots depicting HAPLN1-DA neuron, aggrecan-DA neuron, and HAPLN1-aggrecan-DA neuron puncta densities in young-adult ( n = 8 mice), aging-unimpaired (AU; n = 6 mice), and aging-impaired (AI; n = 4 mice) mice (n-Way ANOVA; two-sided; HAPLN1-DA: p = 0.029; Aggrecan-DA: p = 0.62; HAPLN-Aggrecan-DA: p = 0.031). d Schematic of the analysis strategy used to examine hyaluronan and Homer2 on dopamine neurons (Homer-DA neuron). Experiments were performed once on a single cohort of mice. e Boxplots depicting homer-DA neuron puncta densities in young-adult (black) and late-middle-aged (gray) sedentary (squares) and behavior-trained (triangles) mice (n-way ANOVA; two-sided; Behavior: p = 0.65; n = 8 young-sedentary; 12 young-behavior; 8 middle-aged-sedentary; 12 middle-aged-behavior mice). f Relationship between homer-DA neuron puncta densities and performance on foraging task (robust regression; two-sided; Young: p = 0.91; Middle-aged: p = 0.039). g Scatter plots of hyaluronan-DA neuron puncta densities plotted against Homer2-DA neuron puncta densities in sedentary and behavior-trained mice (robust regression; two-sided; Young Sedentary: p = 0.34; Middle-aged Sedentary: p = 0.14; Young Behavior: p = 0.0036; Middle-aged Behavior: p = 0.0068). In all boxplots, boxes represent interquartile ranges (IQR; 25–75 percentiles), middle lines represent medians, and whiskers extend +/− 1.5*IQR. Source data are provided in the file - Fig. 7 and all statistics are provided in Supplementary Data . * represents p < 0.05.
    Goat Anti Hapln1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hapln1/Human+HAPLN1+Antibody/bio_rxiv__2025__08__13__670146-131-14-16
    Average 94 stars, based on 1 article reviews
    goat anti hapln1 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    R&D Systems af2608
    a Left: photomicrographs of immunohistochemically labeled hyaluronan and proteoglycan link protein 1 <t>(HAPLN1),</t> <t>aggrecan,</t> and tyrosine hydroxylase (TH) from the ventral tegmental area (VTA) of a late-middle-aged mouse. Numbered images in middle panel correspond to numbered fields of view within white squares in the left panels. Right panels depict the fields of view delineated by white squares in middle panel. Right: photomicrographs depicting HAPLN1 and aggrecan deposition on dopamine neuron surfaces, and the peri-dopamine neuron region of interest used to estimate protein abundances at neuronal membranes. Experiments were performed once on a single cohort of mice. b Boxplots depicting field of view coverage of HAPLN1 and aggrecan in the VTA of young-adult (black; n = 8 mice), aging-unimpaired (AU; green; n = 6 mice), and aging-impaired (AI; yellow; n = 4 mice) mice (n-Way ANOVA; post-hoc Tukey-Kramer; <t>HAPLN:</t> p = 0.022; Aggrecan: p = 0.25). c Boxplots depicting HAPLN1-DA neuron, aggrecan-DA neuron, and HAPLN1-aggrecan-DA neuron puncta densities in young-adult ( n = 8 mice), aging-unimpaired (AU; n = 6 mice), and aging-impaired (AI; n = 4 mice) mice (n-Way ANOVA; two-sided; HAPLN1-DA: p = 0.029; Aggrecan-DA: p = 0.62; HAPLN-Aggrecan-DA: p = 0.031). d Schematic of the analysis strategy used to examine hyaluronan and Homer2 on dopamine neurons (Homer-DA neuron). Experiments were performed once on a single cohort of mice. e Boxplots depicting homer-DA neuron puncta densities in young-adult (black) and late-middle-aged (gray) sedentary (squares) and behavior-trained (triangles) mice (n-way ANOVA; two-sided; Behavior: p = 0.65; n = 8 young-sedentary; 12 young-behavior; 8 middle-aged-sedentary; 12 middle-aged-behavior mice). f Relationship between homer-DA neuron puncta densities and performance on foraging task (robust regression; two-sided; Young: p = 0.91; Middle-aged: p = 0.039). g Scatter plots of hyaluronan-DA neuron puncta densities plotted against Homer2-DA neuron puncta densities in sedentary and behavior-trained mice (robust regression; two-sided; Young Sedentary: p = 0.34; Middle-aged Sedentary: p = 0.14; Young Behavior: p = 0.0036; Middle-aged Behavior: p = 0.0068). In all boxplots, boxes represent interquartile ranges (IQR; 25–75 percentiles), middle lines represent medians, and whiskers extend +/− 1.5*IQR. Source data are provided in the file - Fig. 7 and all statistics are provided in Supplementary Data . * represents p < 0.05.
    Af2608, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hapln1/Human+HAPLN1+Antibody/pm40748756-239-84-81
    Average 94 stars, based on 1 article reviews
    af2608 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    a Left: photomicrographs of immunohistochemically labeled hyaluronan and proteoglycan link protein 1 (HAPLN1), aggrecan, and tyrosine hydroxylase (TH) from the ventral tegmental area (VTA) of a late-middle-aged mouse. Numbered images in middle panel correspond to numbered fields of view within white squares in the left panels. Right panels depict the fields of view delineated by white squares in middle panel. Right: photomicrographs depicting HAPLN1 and aggrecan deposition on dopamine neuron surfaces, and the peri-dopamine neuron region of interest used to estimate protein abundances at neuronal membranes. Experiments were performed once on a single cohort of mice. b Boxplots depicting field of view coverage of HAPLN1 and aggrecan in the VTA of young-adult (black; n = 8 mice), aging-unimpaired (AU; green; n = 6 mice), and aging-impaired (AI; yellow; n = 4 mice) mice (n-Way ANOVA; post-hoc Tukey-Kramer; HAPLN: p = 0.022; Aggrecan: p = 0.25). c Boxplots depicting HAPLN1-DA neuron, aggrecan-DA neuron, and HAPLN1-aggrecan-DA neuron puncta densities in young-adult ( n = 8 mice), aging-unimpaired (AU; n = 6 mice), and aging-impaired (AI; n = 4 mice) mice (n-Way ANOVA; two-sided; HAPLN1-DA: p = 0.029; Aggrecan-DA: p = 0.62; HAPLN-Aggrecan-DA: p = 0.031). d Schematic of the analysis strategy used to examine hyaluronan and Homer2 on dopamine neurons (Homer-DA neuron). Experiments were performed once on a single cohort of mice. e Boxplots depicting homer-DA neuron puncta densities in young-adult (black) and late-middle-aged (gray) sedentary (squares) and behavior-trained (triangles) mice (n-way ANOVA; two-sided; Behavior: p = 0.65; n = 8 young-sedentary; 12 young-behavior; 8 middle-aged-sedentary; 12 middle-aged-behavior mice). f Relationship between homer-DA neuron puncta densities and performance on foraging task (robust regression; two-sided; Young: p = 0.91; Middle-aged: p = 0.039). g Scatter plots of hyaluronan-DA neuron puncta densities plotted against Homer2-DA neuron puncta densities in sedentary and behavior-trained mice (robust regression; two-sided; Young Sedentary: p = 0.34; Middle-aged Sedentary: p = 0.14; Young Behavior: p = 0.0036; Middle-aged Behavior: p = 0.0068). In all boxplots, boxes represent interquartile ranges (IQR; 25–75 percentiles), middle lines represent medians, and whiskers extend +/− 1.5*IQR. Source data are provided in the file - Fig. 7 and all statistics are provided in Supplementary Data . * represents p < 0.05.

    Journal: Nature Communications

    Article Title: Midbrain extracellular matrix and microglia are associated with cognition in aging mice

    doi: 10.1038/s41467-025-66434-z

    Figure Lengend Snippet: a Left: photomicrographs of immunohistochemically labeled hyaluronan and proteoglycan link protein 1 (HAPLN1), aggrecan, and tyrosine hydroxylase (TH) from the ventral tegmental area (VTA) of a late-middle-aged mouse. Numbered images in middle panel correspond to numbered fields of view within white squares in the left panels. Right panels depict the fields of view delineated by white squares in middle panel. Right: photomicrographs depicting HAPLN1 and aggrecan deposition on dopamine neuron surfaces, and the peri-dopamine neuron region of interest used to estimate protein abundances at neuronal membranes. Experiments were performed once on a single cohort of mice. b Boxplots depicting field of view coverage of HAPLN1 and aggrecan in the VTA of young-adult (black; n = 8 mice), aging-unimpaired (AU; green; n = 6 mice), and aging-impaired (AI; yellow; n = 4 mice) mice (n-Way ANOVA; post-hoc Tukey-Kramer; HAPLN: p = 0.022; Aggrecan: p = 0.25). c Boxplots depicting HAPLN1-DA neuron, aggrecan-DA neuron, and HAPLN1-aggrecan-DA neuron puncta densities in young-adult ( n = 8 mice), aging-unimpaired (AU; n = 6 mice), and aging-impaired (AI; n = 4 mice) mice (n-Way ANOVA; two-sided; HAPLN1-DA: p = 0.029; Aggrecan-DA: p = 0.62; HAPLN-Aggrecan-DA: p = 0.031). d Schematic of the analysis strategy used to examine hyaluronan and Homer2 on dopamine neurons (Homer-DA neuron). Experiments were performed once on a single cohort of mice. e Boxplots depicting homer-DA neuron puncta densities in young-adult (black) and late-middle-aged (gray) sedentary (squares) and behavior-trained (triangles) mice (n-way ANOVA; two-sided; Behavior: p = 0.65; n = 8 young-sedentary; 12 young-behavior; 8 middle-aged-sedentary; 12 middle-aged-behavior mice). f Relationship between homer-DA neuron puncta densities and performance on foraging task (robust regression; two-sided; Young: p = 0.91; Middle-aged: p = 0.039). g Scatter plots of hyaluronan-DA neuron puncta densities plotted against Homer2-DA neuron puncta densities in sedentary and behavior-trained mice (robust regression; two-sided; Young Sedentary: p = 0.34; Middle-aged Sedentary: p = 0.14; Young Behavior: p = 0.0036; Middle-aged Behavior: p = 0.0068). In all boxplots, boxes represent interquartile ranges (IQR; 25–75 percentiles), middle lines represent medians, and whiskers extend +/− 1.5*IQR. Source data are provided in the file - Fig. 7 and all statistics are provided in Supplementary Data . * represents p < 0.05.

    Article Snippet: Sections were washed in 1 M PBS (4 × 10 min) and then incubated with streptavidin-conjugated AlexaFluor-647 in the 1% BSA and 0.1% saponin block solution for 2 h. The tissue underwent another 4 × 10 min wash in 1 M PBS, and then was blocked again in 5% normal donkey serum with no additional permeabilization agent for 1 h and was then incubated overnight with mild agitation in a solution containing different combinations of goat anti-GFP (1:1000; Frontier Institute cat: GFP-go-Af1480), rabbit-anti-IBA1 (1:500; Wako cat: 019-19741), chicken anti-TH (1:500; Aves cat: TYH), rabbit anti-Homer2 (1:2000; Synaptic Systems cat: 160 003), mouse anti-Vglut1 (1:2000; DSBH cat: N28/9), biotinylated WFA (1:100; Vector Labs, B-1355), rabbit anti-aggrecan (1:200; Sigma Aldrich AB1031), goat-anti HAPLN (1:200; R&D Systems cat: AF2608) and the biotinylated HABP lectin in 5% NDS solution.

    Techniques: Labeling